EUVIMEDEUVIMED entdecken
Systematische Übersicht

Immunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature

Krystallenia I Alexandraki, Eirini Papadimitriou, Ariadni Spyroglou, Angeliki Karapanagioti, Ioanna Antonopoulou, Irini Theohari, Odysseas Violetis, Georgios C Sotiropoulos, Stamatios Theocharis, Gregory A Kaltsas

Endocrine · 2024

DOI: 10.1007/s12020-024-04079-6 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endocrine, 2024. Verfasst von Krystallenia I Alexandraki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Surgery, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. alexandrakik@gmail.…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Receptors, Eph Family, Intestinal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Erythropoietin-producing hepatocellular (EPH) receptors are the largest known family of tyrosine kinases receptors (TKR) in humans, implicated in cell proliferation, adhesion, migration, tumor angiogenesis, invasion and metastasis. The aim of the present study is to assess the expression of EPHs in neuroendocrine neoplasms (NENs). METHODS: Immunohistochemical staining of specimens of 30 patients with gastroenteropancreatic and lung NENs was performed for EPH-A1, EPH-A2, EPH-A4, EPH-A5 protein expression, in addition to ki-67 multiplication index and programmed death-ligand 1. Additionally, we performed a systematic review of the available literature in three different databases reporting on the expression of EPH in all neuroendocrine neoplasms. RESULTS: Positive expression was seen in 16/19 (84%) specimens for EPH-A1, 15/23 (65%) for EPH-A2, 21/24 (88%) for EPH-A4, 24/26 (92%) for EPH-A5. EPH-A1 was expressed in 9/9 pancreatic, 3/4 small intestine, but not in one lung NEN, EPH-A2 in 5/10 pancreatic, 3/4 small intestine and lung, and in one of each of gastric, appendix, colorectal, and cervical NENs, respectively. EPH-A4 showed positive expression in 9/11 pancreatic, 4/4 small intestine, 3/3 lung specimens and EPH-A5 in 10/11, 4/4 and 4/4, respectively. Data retrieved from the systematic review of the literature in combination with the data from the present study are suggestive of a frequent EPH expression in pituitary, thyroid, lung and gastroenteropancreatic NENs, yet, with varying expressions of the single receptor subtypes. CONCLUSION: EPHs may have a role in NEN tumorigenesis, prognosis as well as a role in the evolving molecular-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsReceptors, Eph FamilyIntestinal NeoplasmsStomach NeoplasmsLung NeoplasmsGastrointestinal NeoplasmsHumansMaleFemaleMiddle AgedImmunohistochemistryAgedAdult

Stichwörter der Autor:innen

EPH-A1EPH-A2EPH-A4EPH-A5Ephrin receptorNeuroendocrine tumorsPD-L1

Substanzen

Receptors, Eph Family

Autor:innen und Institutionen

  • Second Department of Surgery, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. alexandrakik@gmail.com.
  • Endocrine Unit, First Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Second Department of Surgery, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Second Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Athens, Greece.

Zitieren

APA

Alexandraki, K. I., Papadimitriou, E., Spyroglou, A., Karapanagioti, A., Antonopoulou, I., Theohari, I., Violetis, O., Sotiropoulos, G. C., Theocharis, S., & Kaltsas, G. A. (2024). Immunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature. Endocrine. https://doi.org/10.1007/s12020-024-04079-6

Vancouver

Alexandraki KI, Papadimitriou E, Spyroglou A, Karapanagioti A, Antonopoulou I, Theohari I, et al. Immunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature. Endocrine. 2024. doi:10.1007/s12020-024-04079-6

BibTeX
@article{Alexandraki2024,
  author = {Alexandraki, Krystallenia I and Papadimitriou, Eirini and Spyroglou, Ariadni and Karapanagioti, Angeliki and Antonopoulou, Ioanna and Theohari, Irini and Violetis, Odysseas and Sotiropoulos, Georgios C and Theocharis, Stamatios and Kaltsas, Gregory A},
  title = {Immunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature},
  journal = {Endocrine},
  year = {2024},
  doi = {10.1007/s12020-024-04079-6}
}
Kostenlos starten →